Skip to main content

Clinical Outcomes

Long-term results you can trust

U.S. Pivotal Clinical Trials: Five year data across ALL etiologies.

U.S. IDE Clinical Trials: Five year data across ALL etiologies.

Download brochure

Real-world data

SURPASS Registry results

Graphic with real world data

Download flyer

GREAT data highlights through three years1 across ALL etiologies

GREAT Registry Results graphic
video thumbnail

5-year Outcomes: U.S. IDE Clinical Trial, Traumatic Aortic Transection

Mark Farber, M.D., National Principal Investigator provides his perspective on key study outcomes

View video (3:44)

Time-tested innovation

time-tested innovation graphic

* Migrations are reported as those requiring reintervention.

Rates are based on physician experience as reported for 127 subjects in Europe within a 30 day follow-up period. European-Post Approval Registry: Observational Registry Characterizing the Performance and Feature Use of the GORE® TAG® Conformable Thoracic Stent Graft Featuring ACTIVE CONTROL System. (data on file 2017; W.L. Gore & Associates, Inc; Flagstaff, AZ.)

Note: Only serious endoleaks are reported in GREAT (i.e., requiring reintervention).

§ Data on file; W.L. Gore & Associates, Inc.; Flagstaff, AZ.

  1. W. L. Gore & Associates. 'GREAT' Global Registry for Endovascular Aortic Treatment - Outcomes Evaluation. Bethesda, MD: National Library of Medicine; 2012. Available from: NLM Identifier: NCT01658787. Published August 7, 2012. Updated: September 29, 2021. Accessed June 7, 2022.

eIFU Symbol

Refer to Instructions for Use at for a complete description of all applicable indications, warnings, precautions and contraindications for markets where this product is available. RXOnly

Related to this product